Skip to main content
Clinical Trials/NCT05134753
NCT05134753
Unknown
Phase 3

Platelet Rich Fibrin Versus Advanced Platelet Rich Fibrin as Bone Graft Material in Sinus Augmentation (Randomized Controlled Clinical Trial)

Cairo University0 sites32 target enrollmentJanuary 30, 2022
ConditionsMaxillary Sinus

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Maxillary Sinus
Sponsor
Cairo University
Enrollment
32
Primary Endpoint
Bone quality
Last Updated
4 years ago

Overview

Brief Summary

In the present study the main hypothesis , Advanced PRF will improve the bone quality and quantity in sinus augmentation

Registry
clinicaltrials.gov
Start Date
January 30, 2022
End Date
September 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mahinour magdy mohamed

Resident oral surgery

Cairo University

Eligibility Criteria

Inclusion Criteria

  • The Patients with missing posterior maxillary teeth with insufficient available bone for implant placement indicating the need for maxillary sinus floor augmentation before implantation.
  • The Patients should be free from any systemic disease that may affect normal healing of bone, and predictable outcome.
  • The Patients should be free from any sinus disease that might affect the health and integrity of the sinus lining.
  • Assign an informed consent to be involved in the study.

Exclusion Criteria

  • Patients with any systemic disease that may affect normal healing.
  • Patients with any sinus disease.

Outcomes

Primary Outcomes

Bone quality

Time Frame: Six months

Histological analysis for core biopsies Available bone quality will be evaluated by measuring the Total Bone Volume (TBV)

Secondary Outcomes

  • Bone quantity(Six months)

Similar Trials